English
简体中文
Total: £ 56.28
2024-10-17 | Pages: 126 | Tables: 240
Human albumin solutions are used in a range of medical and surgical problems. The global market for Human Albumin Solution was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % dur...
2024-10-17 | Pages: 125 | Tables: 242
Cryopreserved hepatocytes as an in vitro tool for generating physiologically relevant results The global market for Cryopreserved Animal Hepatocytes was estimated to be worth US$ 115 million in 2023 and is forecast to a readjusted size of US$ 151.8 m...
2024-10-17 | Pages: 131 | Tables: 243
Cryopreserved hepatocytes as an in vitro tool for generating physiologically relevant results The global market for Cryopreserved Human Hepatocytes was estimated to be worth US$ 115 million in 2023 and is forecast to a readjusted size of US$ 151.8 mi...
2024-10-17 | Pages: 100 | Tables: 218
Solute transporter carrier (SLC)-expressing cells play an important role in the absorption, distribution, and clearance of a wide variety of drugs from the kidney and other organs. The global market for Solute Transporter Carrier(SLC) Cells was esti...
2024-10-17 | Pages: 126 | Tables: 244
Cryopreserved hepatocytes as an in vitro tool for generating physiologically relevant results The global market for Cryopreserved Hepatocytes was estimated to be worth US$ 565 million in 2023 and is forecast to a readjusted size of US$ 797.4 million ...
2024-10-17 | Pages: 152 | Tables: 292
Transformation of bacteria with plasmids is important because bacteria are used as the means for both storing and replicating plasmids. E. coli cells are more likely to incorporate foreign DNA if their cell walls are altered so that DNA can pass thro...
2024-10-17 | Pages: 158 | Tables: 277
Transformation of bacteria with plasmids is important because bacteria are used as the means for both storing and replicating plasmids. E. coli cells are more likely to incorporate foreign DNA if their cell walls are altered so that DNA can pass thro...
2024-10-17 | Pages: 100 | Tables: 182
The global market for Rabbit Polyclonal Antibodies was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Rabbit Polyc...
2024-10-17 | Pages: 109 | Tables: 184
The global market for Cerebral Vein Thrombosis Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market...
2024-10-17 | Pages: 97 | Tables: 149
The global market for Ventricular Fibrillation Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market...
2024-10-17 | Pages: 108 | Tables: 177
The global market for Antimicrobial Technology was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Antimicrobial Te...
2024-10-17 | Pages: 135 | Tables: 210
The global market for Thymus Cancer Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 bi...
2024-10-17 | Pages: 150 | Tables: 236
The global market for Duane Syndrome Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 b...
2024-10-17 | Pages: 107 | Tables: 187
The global market for Nerve Entrapment Syndrome Therapeutics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. The global pharmaceutical ma...
2024-10-17 | Pages: 113 | Tables: 189
The global market for Ventral Hernia Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 b...
